Kohnen T, Klaproth O K
Klinik für Augenheilkunde, Johann Wolfgang Goethe-Universität, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland.
Ophthalmologe. 2008 Nov;105(11):991-2, 994-8. doi: 10.1007/s00347-008-1827-7.
Removal of the crystalline lens and its replacement by an intraocular lens (IOL) is known as refractive lens exchange (RLE). RLE is performed to correct high ametropia or aniseikonia. Crystalline lens removal always leads to a complete loss of accommodation; therefore, RLE should mainly be used for patients with beginning or existing presbyopia. RLE patients usually have a good best-corrected visual acuity, which is the default value for the postoperative uncorrected visual acuity. To reach this goal, microincisional and astigmatism-neutral implantation techniques as well as special IOL optic designs are available. These optic designs offer each patient individualized best visual performance. In spite of the high requirements for postoperative optical quality, RLE can lead to an effective, safe, predictable, and stable outcome with a low risk of complications.
摘除晶状体并用人工晶状体(IOL)进行置换被称为屈光性晶状体置换术(RLE)。进行RLE是为了矫正高度屈光不正或两眼像差。晶状体摘除总会导致调节功能完全丧失;因此,RLE主要应用于初发或已有老花眼的患者。RLE患者通常具有良好的最佳矫正视力,这是术后未矫正视力的默认值。为实现这一目标,可采用微切口和散光中和植入技术以及特殊的IOL光学设计。这些光学设计为每位患者提供个性化的最佳视觉性能。尽管对术后光学质量要求很高,但RLE可带来有效、安全、可预测且稳定的结果,并发症风险较低。